Sarcoidosis – Pulmonary (Lung) Involvement

Overview

Sarcoidosis is a systemic inflammatory disease characterized by the formation of non‑caseating granulomas—small clumps of immune cells—in various organs. When the lungs and the lymph nodes within the chest are affected, the condition is referred to as pulmonary sarcoidosis. It is the most common manifestation of sarcoidosis, occurring in up to 90 % of patients.^[1][2] The exact cause is unknown, but a combination of genetic susceptibility and environmental triggers (e.g., certain infections or occupational exposures) is thought to drive an abnormal immune response.

Symptoms Checklist

• Persistent dry cough
• Shortness of breath, especially during exertion
• Chest tightness or pain
• Wheezing or noisy breathing
• Unexplained fatigue
• Fever or night sweats (less common)
• Weight loss
• Skin lesions (e.g., erythema nodosum) – may indicate systemic disease
• Joint pain or swelling

Note: Many people with early pulmonary sarcoidosis are asymptomatic and the disease is discovered incidentally on a chest X‑ray.

Risk Factors

• Age: Most commonly diagnosed between 20–40 years.
• Sex: Slight female predominance in some studies.
• Race/Ethnicity: Higher incidence in African‑American individuals (up to 3‑4 × the rate in whites) and in people of Scandinavian descent.^[3]
• Family History: First‑degree relatives with sarcoidosis increase risk, suggesting a genetic component.
• Environmental/Occupational Exposures: Dusts (e.g., silica, beryllium), agricultural chemicals, and certain infectious agents have been implicated.
• Smoking: Unlike many lung diseases, current smoking appears to be protective against developing sarcoidosis, though smokers who do develop it may have a more severe course.

Diagnosis

Diagnosing pulmonary sarcoidosis involves a combination of clinical, radiographic, and pathological findings:

1. Medical History & Physical Exam: Assessment of symptoms, exposure history, and skin or eye findings.
2. Chest Imaging:
   • Chest X‑ray: Classic bilateral hilar lymphadenopathy (BHL) in ~90 % of cases.
   • High‑Resolution CT (HRCT): Provides detailed view of parenchymal nodules, ground‑glass opacities, and fibrosis.
3. Pulmonary Function Tests (PFTs): Typically reveal a restrictive pattern and reduced diffusing capacity (DLCO). Obstructive changes can also occur.
4. Laboratory Tests: Elevated serum angiotensin‑converting enzyme (ACE) and hypercalcemia may support the diagnosis but are not definitive.
5. Biopsy: Histologic confirmation of non‑caseating granulomas from transbronchial lung biopsy, mediastinoscopy, or less invasive sites (e.g., skin, lymph node) is the gold standard.^[4]
6. Exclusion of Other Causes: Infections (TB, fungal), hypersensitivity pneumonitis, and malignancy must be ruled out.

Treatment Options

Treatment is individualized based on disease severity, organ involvement, and symptom burden.

Medical Therapies

• Observation: Asymptomatic patients with normal lung function may be monitored without medication.
• Corticosteroids: First‑line for symptomatic or progressive disease (e.g., prednisone 20‑40 mg daily, tapering over months). Long‑term use requires monitoring for side effects.
• Steroid‑Sparing Agents:
  • Methotrexate (10‑25 mg weekly)
  • Azathioprine (1.5‑2 mg/kg/day)
  • Mycophenolate mofetil
  Used to reduce steroid exposure or when steroids are ineffective.
• Biologic Therapy: Tumor necrosis factor‑α (TNF‑α) inhibitors (e.g., infliximab, adalimumab) for refractory disease.
• Antimalarials (Hydroxychloroquine): Helpful for skin lesions and hypercalcemia.

Home & Supportive Care

• Inhaled bronchodilators (short‑acting β‑agonists) for wheeze or bronchospasm.
• Pulmonary rehabilitation to improve exercise tolerance.
• Vaccinations: annual influenza, COVID‑19, and pneumococcal vaccines to reduce respiratory infections.
• Calcium & vitamin D management to avoid hypercalcemia (monitor serum levels).

Prevention

Because the exact cause of sarcoidosis is unknown, specific primary prevention is not possible. However, risk can be reduced by:

• Limiting exposure to known occupational dusts (use respirators, proper ventilation).
• Maintaining good indoor air quality (control mold, avoid smoking).
• Prompt treatment of respiratory infections that could exacerbate lung inflammation.
• Regular medical follow‑up for individuals with a family history or early radiographic findings.

Living With Pulmonary Sarcoidosis

• Regular Monitoring: Schedule pulmonary function tests and imaging as recommended by your pulmonologist (often every 6–12 months).
• Medication Adherence: Take steroids or steroid‑sparing agents exactly as prescribed; never stop abruptly.
• Exercise: Low‑impact aerobic activities (walking, swimming, cycling) improve stamina and lung capacity.
• Energy Conservation: Pace activities, use assistive devices if needed, and prioritize rest.
• Nutrition: Balanced diet rich in fruits, vegetables, lean protein; limit high‑salt foods if on steroids.
• Stress Management: Mind‑body techniques (yoga, meditation) can help with fatigue and anxiety.
• Support Networks: Join sarcoidosis patient groups (e.g., Sarcoidosis Foundation) for education and emotional support.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

• Sudden, severe shortness of breath or inability to speak full sentences.
• Chest pain that is crushing, radiates to the arm/jaw, or is associated with sweating.
• Rapid heart rate (tachycardia) with dizziness or fainting.
• New or worsening wheezing that does not improve with rescue inhaler.
• High fever (> 101 °F / 38.3 °C) with chills.
• Signs of hypercalcemia: nausea, vomiting, constipation, confusion.

Disclaimer: This guide is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified health‑care provider regarding any medical condition or before starting new therapies.

References:
[1] Mayo Clinic. “Sarcoidosis.” https://www.mayoclinic.org.
[2] National Institutes of Health (NIH) – National Heart, Lung, and Blood Institute. “Sarcoidosis.” https://www.nhlbi.nih.gov.
[3] CDC. “Sarcoidosis – Epidemiology.” https://www.cdc.gov.
[4] Cleveland Clinic. “Sarcoidosis: Diagnosis and Treatment.” https://my.clevelandclinic.org.
[5] Johns Hopkins Medicine. “Pulmonary Sarcoidosis.” https://www.hopkinsmedicine.org.